Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) posted its earnings results on Thursday. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05, Zacks reports. The business had revenue of $3.65 billion for the quarter, compared to analyst estimates of $3.88 billion. Daiichi Sankyo had a net margin of 15.40% and a return on equity of 18.39%.
Daiichi Sankyo Stock Down 6.1%
Shares of OTCMKTS:DSNKY traded down $1.18 during midday trading on Friday, reaching $18.20. The company had a trading volume of 959,665 shares, compared to its average volume of 428,224. The company has a quick ratio of 1.60, a current ratio of 2.31 and a debt-to-equity ratio of 0.06. The business’s 50 day moving average price is $21.81 and its 200 day moving average price is $23.51. The stock has a market cap of $34.48 billion and a PE ratio of 17.17. Daiichi Sankyo has a 1-year low of $17.80 and a 1-year high of $28.21.
Wall Street Analyst Weigh In
Separately, Zacks Research downgraded Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Daiichi Sankyo currently has a consensus rating of “Moderate Buy”.
Daiichi Sankyo Company Profile
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Articles
- Five stocks we like better than Daiichi Sankyo
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- The Crash Has Already Started (Most Just Don’t See It Yet)
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
